Evolent Health (EVH) Operating Leases (2019 - 2026)

Evolent Health has reported Operating Leases for 8 years, with the latest figure at $3.2 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases fell 79.72% year-over-year to $3.2 million; the trailing twelve-month figure through Mar 2026 stood at $3.2 million (down 79.72% YoY), and the FY2025 full-year result was $3.8 million, down 84.71% from the prior year.
• Operating Leases for Q1 2026 stood at $3.2 million, down from $3.8 million in the prior quarter.
• The five-year high for Operating Leases was $65.0 million in Q2 2022, with the low at $3.2 million in Q1 2026.
• Average Operating Leases over 5 years is $37.5 million, with a median of $38.0 million recorded in 2023.
• Year-over-year, Operating Leases grew 10.84% in 2022 and plunged 84.71% in 2025.
• Tracing EVH's Operating Leases over 5 years: stood at $56.0 million in 2022, then sank by 32.14% to $38.0 million in 2023, then tumbled by 34.31% to $25.0 million in 2024, then sank by 84.71% to $3.8 million in 2025, then dropped by 17.23% to $3.2 million in 2026.
• The last three Operating Leases figures came in at $3.2 million (Q1 2026), $3.8 million (Q4 2025), and $22.4 million (Q3 2025), per Business Quant data.

Peer Comparison